Prodrome Sciences is a biotech company developing technologies derived primarily from the research of its founder, Dayan Goodenowe. The basic principle underlying the Prodrome technology is that diseases result from, and well as bring about, changes in the biochemical states of the organism, and an understanding of the biochemical state of a healthy person and the changes it undergoes in disease can be a powerful approach to not just diagnosis, but also in treatment.

The systems-level information about the biochemical state of the body, as measured by the presence or absence of specific metabolites is referred to, conceptually, as a Prodrome.

Using advanced blood testing technology and biochemical supplements, Prodrome Sciences is pioneering a new field of research: strategic biochemical reserves.